Department of Nephrology, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.
Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
BMC Pediatr. 2020 May 14;20(1):218. doi: 10.1186/s12887-020-02134-5.
Lipin-1, encoded by LPIN1 gene, serves as an enzyme and a transcriptional co-regulator to regulate lipid metabolism and mitochondrial respiratory chain. Autosomal recessive mutations in LPIN1 were recognized as one of the most common causes of pediatric recurrent rhabdomyolysis in western countries. However, to date, there were only a few cases reported in Asian group. This study aims to report the first pediatric case of recurrent rhabdomyolysis with a novel LPIN1 mutation in China mainland in order to raise the awareness of both pediatricians and patients.
Here we report a Chinese pediatric case of recurrent rhabdomyolysis with compound heterozygous variants (p.Arg388* and p.Arg810Cys) in the LPIN1 gene. The c.2428C > T was a novel missense variant involved Arg-to-Cys substitution at position 810 (p.Arg810Cys), located in the highly conserved region which predicted to be damaging by multiple algorithms. The patient manifested as cola-colored urine, muscle weakness and tenderness, as well as acute kidney injury with peak blood creatine kinase level 109,570 U/l in 19-month old. In his second episode of 9 years old, the symtoms were relatively milder with peak creatine kinase level 50,948 U/l. He enjoyed quite normal life between the bouts but slightly elevation of serum creatine kinase level during the fever or long-term exercises. Prolonged weight training combined with calorie deprivation were speculated to be the triggers of his illness. Prompt symptomatic therapy including fluid therapy and nutritional support was given and the patient recovered soon.
LPIN1-related rhabdomyolysis is still quite new to physicians due to its seemly low-incidence especially in Asian countries. In the future, more active genetic test strategy and detailed prophylactic care education should be taken in patients with severe recurrent rhabdomyolysis, who are the high risk group of LPIN1 genetic defects.
脂肪酶激活蛋白 1(Lipin-1)由 LPIN1 基因编码,作为一种酶和转录共调节剂,参与调节脂质代谢和线粒体呼吸链。常染色体隐性突变是西方儿童复发性横纹肌溶解症的最常见原因之一。然而,迄今为止,亚洲人群仅有少数病例报道。本研究旨在报告中国大陆首例儿童复发性横纹肌溶解症伴 LPIN1 基因突变,以提高儿科医生和患者的认识。
我们报告了一例中国儿童复发性横纹肌溶解症,携带 LPIN1 基因的复合杂合变异(p.Arg388*和 p.Arg810Cys)。c.2428C>T 是一种新的错义变异,导致 810 位的精氨酸被半胱氨酸取代(p.Arg810Cys),位于高度保守区域,多种算法预测该变异具有致病性。患者在 19 个月大时出现茶色尿、肌肉无力和压痛,以及急性肾损伤,肌酸激酶峰值为 109,570 U/l。在他 9 岁时的第二次发作中,症状相对较轻,肌酸激酶峰值为 50,948 U/l。在两次发作之间,他的生活相当正常,但在发烧或长时间运动时,血清肌酸激酶水平略有升高。长时间的重量训练结合热量摄入不足被推测是他发病的诱因。我们给予了对症治疗,包括液体疗法和营养支持,患者很快恢复。
由于其发病率似乎较低,尤其是在亚洲国家,LPIN1 相关的横纹肌溶解症对医生来说仍然相当陌生。在未来,对于反复发生严重横纹肌溶解症的患者,应采取更积极的基因检测策略和详细的预防保健教育,因为这些患者是 LPIN1 基因缺陷的高危人群。